Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia

International Journal of Laboratory Hematology

Volumn 33, Issue 3, 2011, Pages 299-304

  Hwang, Y ^a   Lee, J Y ^a   Mun, Y C ^a   Seong, C M ^a   Chung, W S ^a   Huh, J ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Chronic lymphocytic leukemia; Deletion; Fluorescence in situ hybridization; IgH; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; HUMAN; MULTIPLE MYELOMA; PRIORITY JOURNAL;

AGED; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; FEMALE; GENE DELETION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC;

EID: 79954775763     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2010.01290.x     Document Type: Article

References (17)

1. Aoun P., Blair H.E., Smith L.M., Dave B.J., Lynch J., Weisenburger D.D., Pavletic S.Z. & Sanger W.G. (2004) Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukaemia & Lymphoma 45, 1595-1603.
2. Balcarkova J., Pika T., Urbankova H., Holzerova M., Scudla V., Bacovky J., Indrak K. & Jarosova M. (2009) Deletion of 14q involving IgH gene in patients with multiple myeloma. Haematologica 94(S2), 25. abs. 0062.
3. Barber K.E., Ford A.M., Harris R.L., Harrison C.J. & Moorman A.V. (2004) MLL translocations with concurrent 3' deletions: interpretation of FISH results. Genes Chromosomes Cancer 41, 266-271.
4. Fink S.R., Paternoster S.F., Smoley S.A., Flynn H.C., Geyer S.M., Shanafelt T.D., Lee Y.K., Jelinek D.F., Kay N.E. & Dewald G.W. (2005) Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leukemia Research 29, 253-262.
5. Huntly B.J., Reid A.G., Bench A.J., Campbell L.J., Telford N., Shepherd P., Szer J., Prince H.M., Turner P., Grace C., Nacheva E.P. & Green A.R. (2001) Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 98, 1732-1738.
6. Kolomietz E., Al-Maghrabi J., Brennan S., Karaskova J., Minkin S., Lipton J. & Squire J.A. (2001) Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97, 3581-3588.
7. Kuipers J., Vaandrager J.W., Weghuis D.O., Pearson P.L., Scheres J., Lokhorst H.M., Clevers H. & Bast B.J. (1999) Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines. Cancer Genetics and Cytogenetics 109, 99-107.
8. Küppers R. & Dalla-Favera R. (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580-5594.
9. Nowakowski G.S., Dewald G.W., Hoyer J.D., Paternoster S.F., Stockero K.J., Fink S.R., Smoley S.A., Remstein E.D., Phyliky R.L., Call T.G., Shanafelt T.D., Kay N.E. & Zent C.S. (2005) Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. British Journal Haematology 130, 36-42.
10. Quintero-Rivera F., Nooraie F. & Rao P.N. (2009) Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 190, 33-39.
11. Remstein E.D., Kurtin P.J., Buño I., Bailey R.J., Proffitt J., Wyatt W.A., Hanson C.A. & Dewald G.W. (2000) Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. British Journal Haematology 110, 856-862.
12. Shaffer L.G., Slovak M.L. & Campbell L.J. (eds) (2009) An International System for Human Cytogenetic Nomenclature. S. Karger, Basel.
13. Siebert R., Rosenwald A., Staudt L.M. & Morris S.W. (2001) Molecular features of B-cell lymphoma. Current Opinion in Oncology 13, 316-324.
14. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J & Vardiman JW (eds) (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC, Lyon. pp. 180-182, pp. 200-213
15. Trakhtenbrot L., Hardan I., Koren-Michowitz M., Oren S., Yshoev G., Rechavi G., Nagler A. & Amariglio N. (2010) Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma. Genes Chromosomes Cancer 49, 17-27.
16. Wlodarska I., Matthews C., Veyt E., Pospisilova H., Catherwood M.A., Poulsen T.S., Vanhentenrijk V., Ibbotson R., Vandenberghe P., Morris T.C. & Alexander H.D. (2007) Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events. The Journal of Molecular Diagnostics 9, 47-54.
17. Zelenetz A.D., Cleary M.L. & Levy R. (1993) A submicroscopic interstitial deletion of chromosome 14 frequently occurs adjacent to the t(14;18) translocation breakpoint in human follicular lymphoma. Genes Chromosomes Cancer 6, 140-150.